<?xml version='1.0' encoding='UTF-8'?>
<Organism_Record>
  <Organism_ID>ASD00870000_1</Organism_ID>
  <Organism>Human</Organism>
  <Organism_Latin>Homo sapiens</Organism_Latin>
  <UniProt_ID>P49902</UniProt_ID>
  <Seq_Length>561</Seq_Length>
  <Molecule_Weight>64970</Molecule_Weight>
  <KEGG_ID>hsa:22978</KEGG_ID>
  <Orthology_ID>K01081</Orthology_ID>
  <EBI_ID>EBI-742084</EBI_ID>
  <Function_Summary>May have a critical role in the maintenance of a constant composition of intracellular purine/pyrimidine nucleotides in cooperation with other nucleotidases. Preferentially hydrolyzes inosine 5'-monophosphate (IMP) and other purine nucleotides.</Function_Summary>
  <Catalytic_Mechanism>A 5'-ribonucleotide + H(2)O = a ribonucleoside + phosphate.</Catalytic_Mechanism>
  <Pfam_ID>PF05761:5_nucleotid</Pfam_ID>
  <Allosteric_Activator_Count>6</Allosteric_Activator_Count>
  <Allosteric_Inhibitor_Count>1</Allosteric_Inhibitor_Count>
  <Allosteric_Regulator_Count>3</Allosteric_Regulator_Count>
  <Alias_List>
      <Alias>Cytosolic 5'-nucleotidase II</Alias>
  </Alias_List>
  <Function_List>
    <Funtion>
      <Detail>Catalysis of the reaction: a 5'-ribonucleotide + H2O = a ribonucleoside + phosphate.</Detail>
      <Keyword>5'-nucleotidase activity</Keyword>
      <Ontology_ID>GO:0008253</Ontology_ID>
    </Funtion>
    <Funtion>
      <Detail>Catalysis of a biochemical reaction at physiological temperatures. In biologically catalyzed reactions, the reactants are known as substrates, and the catalysts are naturally occurring macromolecular substances known as enzymes. Enzymes possess specific binding sites for substrates, and are usually composed wholly or largely of protein, but RNA that has catalytic activity (ribozyme) is often also regarded as enzymatic.</Detail>
      <Keyword>Catalytic activity</Keyword>
      <Ontology_ID>GO:0003824</Ontology_ID>
    </Funtion>
    <Funtion>
      <Detail>Catalysis of the hydrolysis of various bonds, e.g. C-O, C-N, C-C, phosphoric anhydride bonds, etc. Hydrolase is the systematic name for any enzyme of EC class 3.</Detail>
      <Keyword>Hydrolase activity</Keyword>
      <Ontology_ID>GO:0016787</Ontology_ID>
    </Funtion>
    <Funtion>
      <Detail>Interacting selectively and non-covalently with a nucleotide, any compound consisting of a nucleoside that is esterified with (ortho)phosphate or an oligophosphate at any hydroxyl group on the ribose or deoxyribose.</Detail>
      <Keyword>Nucleotide binding</Keyword>
      <Ontology_ID>GO:0000166</Ontology_ID>
    </Funtion>
    <Funtion>
      <Detail>Interacting selectively and non-covalently with any metal ion.</Detail>
      <Keyword>Metal ion binding</Keyword>
      <Ontology_ID>GO:0046872</Ontology_ID>
    </Funtion>
    <Funtion>
      <Detail>Interacting selectively and non-covalently with any protein or protein complex (a complex of two or more proteins that may include other nonprotein molecules).</Detail>
      <Keyword>Protein binding</Keyword>
      <Ontology_ID>GO:0005515</Ontology_ID>
    </Funtion>
  </Function_List>
  <Mutation_List>
    <Muntion>
      <Position>136</Position>
      <Original>Gln</Original>
      <Variation>Arg</Variation>
    </Muntion>
    <Muntion>
      <Position>3</Position>
      <Original>Thr</Original>
      <Variation>Ala</Variation>
    </Muntion>
  </Mutation_List>
  <BioProcess_List>
    <BioProcess>
      <Detail>The chemical reactions and pathways resulting in the breakdown of a purine nucleotide, a compound consisting of nucleoside (a purine base linked to a deoxyribose or ribose sugar) esterified with a phosphate group at either the 3' or 5'-hydroxyl group of the sugar.</Detail>
      <Keyword>Purine nucleotide catabolic process</Keyword>
      <Ontology_ID>GO:0006195</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>The chemical reactions and pathways involving a nucleotide, a nucleoside that is esterified with (ortho)phosphate or an oligophosphate at any hydroxyl group on the glycose moiety; may be mono-, di- or triphosphate; this definition includes cyclic nucleotides (nucleoside cyclic phosphates).</Detail>
      <Keyword>Nucleotide metabolic process</Keyword>
      <Ontology_ID>GO:0009117</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>The chemical reactions and pathways involving purine bases, one of the two classes of nitrogen-containing ring compounds found in DNA and RNA, which include adenine and guanine.</Detail>
      <Keyword>Purine base metabolic process</Keyword>
      <Ontology_ID>GO:0006144</Ontology_ID>
    </BioProcess>
  </BioProcess_List>
  <PTM_List>
    <PTM>
      <Position>527</Position>
      <PTM_Type>Phosphoserine</PTM_Type>
    </PTM>
    <PTM>
      <Position>502</Position>
      <PTM_Type>Phosphoserine</PTM_Type>
    </PTM>
  </PTM_List>
  <Molecule_Seq>
    <Protein_Seq>MSTSWSDRLQNAADMPANMDKHALKKYRREAYHRVFVNRSLAMEKIKCFGFDMDYTLAVYKSPEYESLGFELTVERLVSIGYPQELLSFAYDSTFPTRGLVFDTLYGNLLKVDAYGNLLVCAHGFNFIRGPETREQYPNKFIQRDDTERFYILNTLFNLPETYLLACLVDFFTNCPRYTSCETGFKDGDLFMSYRSMFQDVRDAVDWVHYKGSLKEKTVENLEKYVVKDGKLPLLLSRMKEVGKVFLATNSDYKYTDKIMTYLFDFPHGPKPGSSHRPWQSYFDLILVDARKPLFFGEGTVLRQVDTKTGKLKIGTYTGPLQHGIVYSGGSSDTICDLLGAKGKDILYIGDHIFGDILKSKKRQGWRTFLVIPELAQELHVWTDKSSLFEELQSLDIFLAELYKHLDSSSNERPDISSIQRRIKKVTHDMDMCYGMMGSLFRSGSRQTLFASQVMRYADLYAASFINLLYYPFSYLFRAAHVLMPHESTVEHTHVDINEMESPLATRNRTSVDFKDTDYKRHQLTRSISEIKPPNLFPLAPQEITHCHDEDDDEEEEEEEE</Protein_Seq>
    <DNA_Seq>CGCGCGTTGAGGCGGCTGCAGCAGTTGCGCGCTGGGATTGTTGCGGTGCGCTGGAGCCGAATACAAAATACAGTTAAAATAAAATGTCGACCTCCTGGAGTGATCGGTTACAGAATGCAGCAGATATGCCTGCTAACATGGATAAGCATGCCCTGAAAAAGTATCGTCGAGAAGCCTATCATCGGGTGTTTGTGAACCGAAGTTTAGCAATGGAAAAGATAAAGTGTTTTGGTTTTGATATGGATTATACCCTTGCTGTGTACAAGTCCCCAGAGTATGAGTCCCTTGGTTTTGAGCTTACTGTGGAGAGATTAGTTTCTATTGGCTATCCCCAGGAGTTGCTCAGCTTTGCTTATGATTCTACATTCCCTACCAGGGGACTTGTCTTTGACACACTGTATGGAAATCTTTTGAAAGTCGATGCCTATGGAAACCTCTTGGTCTGTGCACATGGATTTAACTTTATAAGGGGACCAGAAACTAGAGAACAGTATCCAAATAAATTTATCCAGCGAGATGATACTGAAAGATTTTACATTCTGAACACACTATTCAACCTACCAGAGACCTACCTGTTGGCCTGCCTAGTAGATTTTTTTACTAATTGTCCCAGATATACCAGTTGTGAAACAGGATTTAAAGATGGGGACCTCTTCATGTCCTACCGGAGTATGTTCCAGGATGTAAGAGATGCTGTTGACTGGGTTCATTACAAGGGCTCCCTTAAGGAAAAGACAGTTGAAAATCTTGAGAAGTATGTAGTCAAAGATGGAAAACTGCCTTTGCTTCTGAGCCGGATGAAGGAAGTAGGGAAAGTATTTCTTGCTACCAACAGTGACTATAAATATACAGATAAAATTATGACTTACCTGTTTGACTTCCCACATGGCCCCAAGCCTGGGAGCTCCCATCGACCATGGCAGTCCTACTTTGACTTGATCTTGGTGGATGCACGGAAACCACTCTTTTTTGGAGAAGGCACAGTACTGCGTCAGGTGGATACTAAAACTGGCAAGCTGAAAATTGGTACCTACACAGGGCCCCTACAGCATGGTATCGTCTACTCAGGAGGTTCTTCTGATACGATCTGTGACCTGTTGGGAGCCAAGGGAAAAGACATTTTGTATATTGGAGATCACATTTTTGGGGACATTTTAAAATCAAAGAAACGGCAAGGGTGGCGAACTTTTTTGGTGATTCCTGAACTCGCACAGGAGCTACATGTCTGGACTGACAAGAGTTCACTTTTCGAAGAACTTCAGAGCTTGGATATTTTCTTGGCTGAACTCTACAAGCATCTTGACAGCAGTAGCAATGAGCGTCCAGACATCAGTTCCATCCAGAGACGTATTAAGAAAGTAACTCATGACATGGACATGTGCTATGGGATGATGGGAAGCCTGTTTCGCAGTGGCTCCCGGCAGACCCTTTTTGCCAGTCAAGTGATGCGTTATGCTGACCTCTATGCAGCATCTTTCATCAACCTGCTGTATTACCCTTTCAGCTACCTCTTCAGGGCTGCCCATGTCTTGATGCCTCATGAATCAACGGTGGAGCACACACACGTAGATATCAATGAGATGGAGTCTCCTCTTGCCACCCGGAACCGCACATCAGTGGATTTCAAAGACACTGACTACAAGCGGCACCAGCTGACACGGTCAATTAGTGAGATTAAACCTCCCAACCTCTTCCCACTGGCCCCCCAGGAAATTACACACTGCCATGACGAAGATGATGATGAAGAGGAGGAGGAGGAGGAAGAATAAGGAGGAAAACCAAAACCCCAAGCACCCATTAAACAAGTCCTGGCAGGACTCACAGGAACAAACGAGGTCCCTGTTAGGGTTCTACTCGGGGGAGGGAGGGGGCTCCATGAAAGGTACGTCTGAAAAGTTTCTGAAGATTTTATTATCATAGATACTTGTTTTGGTTTTGTGTATCTGTACTCTCTGCAGATGGTCCAAAATTGTAATGGAGTCTGTATTAGAAGAAAATAAGGGTAAAATCAGGCTGAACTGCATGTATATGGCTCCACTGTGGCTTGTGACACTTTTAAAATCATCCGTATGTCAGTGTATCTGGATACACGAGGAAAAGGAAAGAGTCTCAGAGTGGAACAAAGAGTGGGAAGAGGTGATCTGTAATGTTACAAATTGTGCTATTACTCCAAGGTCCAACTTTTCCAGTGCATTACATGGTATTGTATATCAGTGGAGAAATGTATTATTTCCATGATCAAATGTAGTCTCTGTTAAGGTCAAGTTTTCTTTTATAAGCCTTTAATTCATCCTCAGTGACTCTGGCAAGGCTGCTTCTCTATCACTGGCTTTGCACAGAAGTATGCTCTACTTGCGTTGCTTTAGGGCAGGATTCTATTTTGAGGGAAAAGACAGTATCCTTATTACCTTTTGTTTGTTTAATAGCACAAATGCTTATTTGTTATCCAAAAACAACCTCCTTCTTATCTGTGATAAATCTATAGAAAGAATTTAGCTGCAAGTGGACAAAGGAACAAGCCCCCAGAAAAGAAAGGGAAGAACTGCCTTCTTATACTACAGAACATGCATTAGTGTGGGCTATATAGCTGTGGCTCATGCTACCCAATTCCAGATTTCTTTGTCCTCTAAGAGTTGATTGCTGTATATTAAAATTGAACATCAGAGGATGGGAAGAGGGCTCTGTAAGCCAGAACCTTACTAAAGTAGAGGGCACAATCAGTGTGAATAAATCCACTTCAGAATCTCAAGTCAAGGCCAGGCACGGCGGCTCACGCCTGTAATCCCAGCACTTTGGGAGGCCGAGACAGGCGGATCACCTGAGGTCGGGAGTTCGAGACCAGCCTTACCAACATGGAGAAACCCCATCTCTACTAAAAATACAAAATTACCTGGGCGTGGTGGTGCATGCCTGTAATCCCATCATCTACTCAGGAGGCTGAGGCAGGAGAATTGCTTGAACCCAGGAGGCGGAGGTTGCAGTGAGCCAGGATTGTGCCATTGCACTCCAGCCTGGGCAACAAGAACAAAACTCCATCTCAAAAAATAAAAATCCCAATCCCAAGTCGAAATCACCTCTTGTTTTAAACAAGAATGAATCATTACTGTGTATGTTAGGGTATTAAAACTGTTTCACCAGTACAGTGAAAGTTGTTTCAACATTTTAAACAAACAGTGGTTATAGACTCTTTCTTTAACCATTGTATATTTTCTTCCATTCTTGTCATTGGTCAATAGGGGAGGGTAGATTAGCTGCT</DNA_Seq>
  </Molecule_Seq>
  <CellLocal_List>
    <AsdMacromoleculeCelllocal>
        <CellLocal>Cytoplasm</CellLocal>
    </AsdMacromoleculeCelllocal>
  </CellLocal_List>
  <Gene>
    <Gene_Name>NT5C2</Gene_Name>
    <Gene_Alias>NT5B; NT5CP; PNT5</Gene_Alias>
    <Gene_ID>22978</Gene_ID>
    <Genbank_ACCN>NM_001134373</Genbank_ACCN>
    <Protein_ACCN>NP_001127845</Protein_ACCN>
    <HGNC_ID>8022</HGNC_ID>
    <Gene_URL>http://www.ncbi.nlm.nih.gov/gene/22978</Gene_URL>
    <UCSC_ID>uc001kwo.3</UCSC_ID>
    <EMBL_ID>ENSG00000076685</EMBL_ID>
  </Gene>
  <PPI_List>
    <PPI>
      <Uniprot_ID>Q6ZVK8</Uniprot_ID>
      <Gene_Name>NUDT18</Gene_Name>
      <EBI_ID>EBI-740486</EBI_ID>
      <PPI_EBI_URL>EBI-742084,EBI-740486</PPI_EBI_URL>
      <Experiment_Number>3</Experiment_Number>
    </PPI>
    <PPI>
      <Uniprot_ID>P51116</Uniprot_ID>
      <Gene_Name>FXR2</Gene_Name>
      <EBI_ID>EBI-740459</EBI_ID>
      <PPI_EBI_URL>EBI-742084,EBI-740459</PPI_EBI_URL>
      <Experiment_Number>3</Experiment_Number>
    </PPI>
    <PPI>
      <Uniprot_ID>Q86TA1</Uniprot_ID>
      <Gene_Name>MOB3B</Gene_Name>
      <EBI_ID>EBI-751703</EBI_ID>
      <PPI_EBI_URL>EBI-742084,EBI-751703</PPI_EBI_URL>
      <Experiment_Number>3</Experiment_Number>
    </PPI>
  </PPI_List>
  <Disease_List>
    <Disease>
      <Disease_Name>Orbital Cellulitis</Disease_Name>
      <Disease_Detail>Orbital Cellulitis</Disease_Detail>
      <Disease_DB>ORB006</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/orbital_cellulitis?search=NT5C2#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Spastic Paraplegia 45</Disease_Name>
      <Disease_Detail>Spastic Paraplegia 45</Disease_Detail>
      <Disease_DB>SPS064</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/spastic_paraplegia_45?search=NT5C2#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Cellulitis</Disease_Name>
      <Disease_Detail>Cellulitis</Disease_Detail>
      <Disease_DB>CLL003</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/cellulitis?search=NT5C2#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Sphenoid Sinusitis</Disease_Name>
      <Disease_Detail>Sphenoid Sinusitis</Disease_Detail>
      <Disease_DB>SPH007</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/sphenoid_sinusitis?search=NT5C2#related_genes</Disease_URL>
    </Disease>
  </Disease_List>
  <PDB_List>
    <PDB>
      <PDB_Title>CRYSTAL STRUCTURE OF HUMAN CYTOSOLIC 5'-NUCLEOTIDASE II (NT5C2, CN-II)</PDB_Title>
      <PDB_ID>2J2C</PDB_ID>
      <Resolution>2.2</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=2J2C</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Crystal structure of human cytosolic 5'-nucleotidase II: insights into allosteric regulation and substrate recognition.</PubMed_Title>
      <Author>Wallden K, et al.</Author>
      <Journal>J Biol Chem. 2007 Jun 15;282(24):17828-36.</Journal>
      <PubMed_ID>17405878</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>CRYSTAL STRUCTURE OF THE D52N VARIANT OF CYTOSOLIC 5'-NUCLEOTIDASE II IN COMPLEX WITH URIDINE 5'-MONOPHOSPHATE AND ADENOSINE TRIPHOSPHATE</PDB_Title>
      <PDB_ID>2XJE</PDB_ID>
      <Resolution>2.3</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=2XJE</PDB_URL>
      <Has_Ligand>Yes</Has_Ligand>
      <ASD_Ligand>ASD00150001</ASD_Ligand>
      <PubMed_Title>Structural Basis for the Allosteric Regulation and Substrate Recognition of Human Cytosolic 5'-Nucleotidase II</PubMed_Title>
      <Author>Wallden, K., et al.</Author>
      <Journal>J.Mol.Biol.(2011)408:684-696</Journal>
      <PubMed_ID>21396942</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>Crystal structure of the D52N variant of cytosolic 5'-nucleotidase II in complex with inorganic phosphate and deoxyadenosine triphosphate</PDB_Title>
      <PDB_ID>2XJD</PDB_ID>
      <Resolution>2.0</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=2XJD</PDB_URL>
      <Has_Ligand>Yes</Has_Ligand>
      <ASD_Ligand>ASD00150001</ASD_Ligand>
      <PubMed_Title>Structural Basis for the Allosteric Regulation and Substrate Recognition of Human Cytosolic 5'-Nucleotidase II.</PubMed_Title>
      <Author>Wallden, K., et al.</Author>
      <Journal>J.Mol.Biol.(2011)408:684</Journal>
      <PubMed_ID>21396942</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>CRYSTAL STRUCTURE OF THE D52N VARIANT OF CYTOSOLIC 5'-NUCLEOTIDASE II IN COMPLEX WITH INOSINE MONOPHOSPHATE AND 2,3-BISPHOSPHOGLYCERATE</PDB_Title>
      <PDB_ID>2XCV</PDB_ID>
      <Resolution>2.3</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=2XCV</PDB_URL>
      <Has_Ligand>Yes</Has_Ligand>
      <ASD_Ligand>ASD03910075</ASD_Ligand>
      <PubMed_Title>Structural Basis for the Allosteric Regulation and Substrate Recognition of Human Cytosolic 5'-Nucleotidase II</PubMed_Title>
      <Author>Wallden, K., et al.</Author>
      <Journal>J.Mol.Biol.(2011)408:684-696</Journal>
      <PubMed_ID>21396942</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>CRYSTAL STRUCTURE OF THE D52N VARIANT OF CYTOSOLIC 5'-NUCLEOTIDASE II WITH A COVALENTLY MODIFIED ASN52</PDB_Title>
      <PDB_ID>2XJF</PDB_ID>
      <Resolution>2.1</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=2XJF</PDB_URL>
      <Has_Ligand>Yes</Has_Ligand>
      <ASD_Ligand>ASD03910075</ASD_Ligand>
      <PubMed_Title>Structural Basis for the Allosteric Regulation and Substrate Recognition of Human Cytosolic 5'-Nucleotidase II</PubMed_Title>
      <Author>Wallden, K., et al.</Author>
      <Journal>J.Mol.Biol.(2011)408:684-696</Journal>
      <PubMed_ID>21396942</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>Human cytosolic 5'-nucleotidase II in complex with Anthraquinone-2,6- disulfonic acid</PDB_Title>
      <PDB_ID>4H4B</PDB_ID>
      <Resolution>2.9</Resolution>
      <PDB_Method>X-ray</PDB_Method>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=4H4B</PDB_URL>
      <Has_Ligand>Yes</Has_Ligand>
      <ASD_Ligand>ASD00870013</ASD_Ligand>
      <PubMed_Title>Identification and characterization of inhibitors of cytoplasmic 5'-nucleotidase cN-II issued from virtual screening.</PubMed_Title>
      <Author>Jordheim, L.P., et al.</Author>
      <Journal>Biochem Pharmacol(2013)85:497-506</Journal>
      <PubMed_ID>23220537</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>CRYSTAL STRUCTURE OF THE D52N VARIANT OF CYTOSOLIC 5'-NUCLEOTIDASE II IN COMPLEX WITH DEOXYGUANOSINE MONOPHOSPHATE AND DEOXYADENOSINE TRIPHOSPHATE</PDB_Title>
      <PDB_ID>2XJB</PDB_ID>
      <Resolution>2.3</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=2XJB</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Structural Basis for the Allosteric Regulation and Substrate Recognition of Human Cytosolic 5'-Nucleotidase II</PubMed_Title>
      <Author>Wallden, K., et al.</Author>
      <Journal>J.Mol.Biol.(2011)408:684-696</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/21396942?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>CRYSTAL STRUCTURE OF HUMAN CYTOSOLIC 5'-NUCLEOTIDASE II IN COMPLEX WITH BERYLLIUM TRIFLUORIDE</PDB_Title>
      <PDB_ID>2JCM</PDB_ID>
      <Resolution>2.15</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=2JCM</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Crystal structure of human cytosolic 5'-nucleotidase II: insights into allosteric regulation and substrate recognition.</PubMed_Title>
      <Author>Wallden K, et al.</Author>
      <Journal>J Biol Chem. 2007 Jun 15;282(24):17828-36.</Journal>
      <PubMed_ID>17405878</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>CRYSTAL STRUCTURE OF HUMAN CYTOSOLIC 5'-NUCLEOTIDASE II IN COMPLEX WITH ADENOSINE</PDB_Title>
      <PDB_ID>2JC9</PDB_ID>
      <Resolution>1.5</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=2JC9</PDB_URL>
      <Has_Ligand>Yes</Has_Ligand>
      <ASD_Ligand>ASD01240004</ASD_Ligand>
      <Ligand_Name>ADENOSINE</Ligand_Name>
      <PubMed_Title>Crystal structure of human cytosolic 5'-nucleotidase II: insights into allosteric regulation and substrate recognition.</PubMed_Title>
      <Author>Wallden K, et al.</Author>
      <Journal>J Biol Chem. 2007 Jun 15;282(24):17828-36.</Journal>
      <PubMed_ID>17405878</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>CRYSTAL STRUCTURE OF THE D52N VARIANT OF CYTOSOLIC 5'-NUCLEOTIDASE II IN COMPLEX WITH INOSINE MONOPHOSPHATE AND ATP</PDB_Title>
      <PDB_ID>2XCW</PDB_ID>
      <Resolution>1.9</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=2XCW</PDB_URL>
      <Has_Ligand>Yes</Has_Ligand>
      <ASD_Ligand>ASD00150001</ASD_Ligand>
      <PubMed_Title>Structural Basis for the Allosteric Regulation and Substrate Recognition of Human Cytosolic 5'-Nucleotidase II</PubMed_Title>
      <Author>Wallden, K., et al.</Author>
      <Journal>J.Mol.Biol.(2011)408:684-696</Journal>
      <PubMed_ID>21396942</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>CRYSTAL STRUCTURE OF THE D52N VARIANT OF CYTOSOLIC 5'-NUCLEOTIDASE II IN COMPLEX WITH GUANOSINE MONOPHOSPHATE AND DIADENOSINE TETRAPHOSPHATE</PDB_Title>
      <PDB_ID>2XJC</PDB_ID>
      <Resolution>2.0</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=2XJC</PDB_URL>
      <Has_Ligand>Yes</Has_Ligand>
      <ASD_Ligand>ASD00870007</ASD_Ligand>
      <PubMed_Title>Structural Basis for the Allosteric Regulation and Substrate Recognition of Human Cytosolic 5'-Nucleotidase II</PubMed_Title>
      <Author>Wallden, K., et al.</Author>
      <Journal>J.Mol.Biol.(2011)408:684-696</Journal>
      <PubMed_ID>21396942</PubMed_ID>
    </PDB>
  </PDB_List>
  <Network_List>
    <Network>
      <Pathway_ID>ko00230</Pathway_ID>
      <Pathway_Title>Purine metabolism</Pathway_Title>
      <Pathway_Class>Metabolism</Pathway_Class>
      <Pathway_Subclass>Nucleotide metabolism</Pathway_Subclass>
    </Network>
    <Network>
      <Pathway_ID>ko00240</Pathway_ID>
      <Pathway_Title>Pyrimidine metabolism</Pathway_Title>
      <Pathway_Class>Metabolism</Pathway_Class>
      <Pathway_Subclass>Nucleotide metabolism</Pathway_Subclass>
    </Network>
    <Network>
      <Pathway_ID>ko00240</Pathway_ID>
      <Pathway_Title>Pyrimidine metabolism</Pathway_Title>
      <Pathway_Class>Metabolism</Pathway_Class>
      <Pathway_Subclass>Nucleotide metabolism</Pathway_Subclass>
    </Network>
    <Network>
      <Pathway_ID>ko00760</Pathway_ID>
      <Pathway_Title>Nicotinate and nicotinamide metabolism</Pathway_Title>
      <Pathway_Class>Metabolism</Pathway_Class>
      <Pathway_Subclass>Metabolism of cofactors and vitamins</Pathway_Subclass>
    </Network>
    <Network>
      <Pathway_ID>ko00760</Pathway_ID>
      <Pathway_Title>Nicotinate and nicotinamide metabolism</Pathway_Title>
      <Pathway_Class>Metabolism</Pathway_Class>
      <Pathway_Subclass>Metabolism of cofactors and vitamins</Pathway_Subclass>
    </Network>
    <Network>
      <Pathway_ID>ko00240</Pathway_ID>
      <Pathway_Title>Pyrimidine metabolism</Pathway_Title>
      <Pathway_Class>Metabolism</Pathway_Class>
      <Pathway_Subclass>Nucleotide metabolism</Pathway_Subclass>
    </Network>
    <Network>
      <Pathway_ID>ko00240</Pathway_ID>
      <Pathway_Title>Pyrimidine metabolism</Pathway_Title>
      <Pathway_Class>Metabolism</Pathway_Class>
      <Pathway_Subclass>Nucleotide metabolism</Pathway_Subclass>
    </Network>
    <Network>
      <Pathway_ID>ko00230</Pathway_ID>
      <Pathway_Title>Purine metabolism</Pathway_Title>
      <Pathway_Class>Metabolism</Pathway_Class>
      <Pathway_Subclass>Nucleotide metabolism</Pathway_Subclass>
    </Network>
    <Network>
      <Pathway_ID>ko00230</Pathway_ID>
      <Pathway_Title>Purine metabolism</Pathway_Title>
      <Pathway_Class>Metabolism</Pathway_Class>
      <Pathway_Subclass>Nucleotide metabolism</Pathway_Subclass>
    </Network>
    <Network>
      <Pathway_ID>ko00240</Pathway_ID>
      <Pathway_Title>Pyrimidine metabolism</Pathway_Title>
      <Pathway_Class>Metabolism</Pathway_Class>
      <Pathway_Subclass>Nucleotide metabolism</Pathway_Subclass>
    </Network>
    <Network>
      <Pathway_ID>ko00230</Pathway_ID>
      <Pathway_Title>Purine metabolism</Pathway_Title>
      <Pathway_Class>Metabolism</Pathway_Class>
      <Pathway_Subclass>Nucleotide metabolism</Pathway_Subclass>
    </Network>
    <Network>
      <Pathway_ID>ko00230</Pathway_ID>
      <Pathway_Title>Purine metabolism</Pathway_Title>
      <Pathway_Class>Metabolism</Pathway_Class>
      <Pathway_Subclass>Nucleotide metabolism</Pathway_Subclass>
    </Network>
    <Network>
      <Pathway_ID>ko00230</Pathway_ID>
      <Pathway_Title>Purine metabolism</Pathway_Title>
      <Pathway_Class>Metabolism</Pathway_Class>
      <Pathway_Subclass>Nucleotide metabolism</Pathway_Subclass>
    </Network>
  </Network_List>
  <Fold>
    <CATH_URL>http://www.cathdb.info/pdb/2jc9</CATH_URL>
  </Fold>
  <AllostericSite_List>
    <AllostericSite>
      <Site_Detail>site,453,Gln;site,154,Asn;site,354,Phe;site,152,Ile;site,456,Arg;site,144,Arg;site,428,His;site,432,Met;site,436,Met;site,127,Phe;site,129,Arg;site,131,Pro;site,134,Arg;site,446,Arg;site,140,Lys</Site_Detail>
      <Site_Reference>Wallden K, et al. J Biol Chem. 2007,282(24):17828-17836.</Site_Reference>
      <Site_Type>Two-site allosteric model</Site_Type>
      <PDB_ID>2JC9</PDB_ID>
      <PubMed_ID>17405878</PubMed_ID>
    </AllostericSite>
  </AllostericSite_List>
  <Enzyme_Nomenclature_List>
    <Enzyme_Nomenclature>
      <Enzyme_DB_ID>3.1.3.5</Enzyme_DB_ID>
      <Enzyme_DB_URL>http://www.chem.qmul.ac.uk/iubmb/enzyme/EC3/1/3/5.html</Enzyme_DB_URL>
    </Enzyme_Nomenclature>
  </Enzyme_Nomenclature_List>
  <Modulator_List>
    <Modulator>
      <ASD_ID>ASD00150001</ASD_ID>
      <Modulator_Feature>Activator</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD00238006</ASD_ID>
      <Modulator_Feature>Regulator</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD00870003</ASD_ID>
      <Modulator_Feature>Activator</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD00870004</ASD_ID>
      <Modulator_Feature>Activator</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD00870006</ASD_ID>
      <Modulator_Feature>Activator</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD00870007</ASD_ID>
      <Modulator_Feature>Activator</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD00870013</ASD_ID>
      <Modulator_Feature>Activator</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD01240004</ASD_ID>
      <Modulator_Feature>Activator</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD01320076</ASD_ID>
      <Modulator_Feature>Regulator</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD03910075</ASD_ID>
      <Modulator_Feature>Activator</Modulator_Feature>
    </Modulator>
  </Modulator_List>
  <Create_Date>2012-05-31</Create_Date>
</Organism_Record>